← Eichor
Condition: Antiphospholipid Syndrome In Pregnancy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Antiphospholipid Syndrome In Pregnancy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07104721A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07123519An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · 1 location(s) · China Immunotech (Beijing) Biotechnology Co., Ltd. · NCT07236762IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Phase 2 · 3 location(s) · David Ware Branch · NCT03152058Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
Phase N/A · 1 location(s) · Insel Gruppe AG, University Hospital Bern · NCT05679206Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Phase N/A · 10 location(s) · Hospital for Special Surgery, New York · NCT00198068
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.